QIN 0.00% 29.5¢ quintis ltd

Ann: Extension of time to hold Annual General Meeting, page-21

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,053 Posts.
    lightbulb Created with Sketch. 2
    there are no phase III trials, you just imagined that.
    this from the HY presentation in february:

    QIN clinical trials.png

    and easily confirmed by visiting clinicaltrials.gov


    Interestingly, despite the HPV trial being completed 3 years ago, there's been no results published and no phase III trial initiated. Suggests to me the results are far from compelling.

    QIN HPV trial.png

    Also no reasons given for terminating the paediatric trial announced above, nor any results for the oral mucositis trial despite it having been completed.

    Anyone who thinks there is massive value in Santalis/Viroxis is deluded.
 
watchlist Created with Sketch. Add QIN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.